A naukri.com initiative
Guardian
3d
168
Image Credit: Guardian
Ministers in ‘active conversation’ with UK drug firms over potential tariffs
- UK government is in discussions with pharmaceutical firms to assess potential impact of US tariffs on exports.
- Negotiations are underway to secure exemptions for British drugmakers from tariffs through a trade deal with the US.
- Industry lobbying intensifies against potential tariffs as they fear disruptions to supply chains and higher costs.
- European pharmaceutical companies also seek assistance from EU to counter US tariffs and maintain operations.
- Concerns arise over the possible shift of pharmaceutical industry from Europe to the US if tariffs are imposed.
- Lib Dems call for an emergency taskforce to ensure security of medicines supply amidst tariff threats.
- Government downplays fears of shortages due to tariffs, while critics warn of disruptions to supply chain.
- Growing worries over potential impacts of tariffs on complex pharmaceutical supply chains and costs.
- Calls for government to strengthen and protect pharmaceutical supply chains to safeguard patients and economy.
- Opportunities and challenges emerge for UK's life sciences sector amid discussions on tariffs and trade deals.
Read Full Article
10 Likes
For uninterrupted reading, download the app